{ "run": { "id": "cmnr13hjl03i4p65811qbwwz4", "region": "US", "assetId": "cmnr13hj303hyp658hp4rb6aa", "ticker": "EL", "snapshotId": "cmnr13hjb03i0p6589785taqv", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:20:32.911Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr13hjb03i0p6589785taqv", "assetId": "cmnr13hj303hyp658hp4rb6aa", "asOf": "2026-04-08T20:00:03.000Z", "snapshot": { "asOf": "2026-04-08T20:00:03.000Z", "quote": { "asOf": "2026-04-08T20:00:03.000Z", "open": null, "price": 71.44, "dayLow": 71.02, "volume": 3672997, "dayHigh": 73.49, "currency": "USD", "prevClose": 69.17, "week52Low": 48.37, "week52High": 121.64 }, "fundamentals": { "pe": -25.6507936507937, "beta": 1.22643244222302, "epsTTM": -3.15, "fcfTTM": 407000000, "growth": { "epsYoy": -3.889908256880734, "revenueYoy": -0.7048024570710596 }, "sector": "Perfumes, Cosmetics & Other Toilet Preparations", "margins": { "net": 0.03830692835185623, "gross": 0.7649562544336722, "operating": 0.09482147079687869 }, "website": "http://elcompanies.com", "industry": "Cosmetics", "pegRatio": 0.0659418987720875, "ebitdaTTM": 683000000, "forwardPe": 37.0642201834862, "marketCap": 17000000000, "totalCash": 2921000000, "totalDebt": 7317000000, "debtEquity": 1.89314359637775, "quickRatio": 0.818951241950322, "revenueTTM": 4229000000, "companyName": "ESTEE LAUDER COMPANIES INC", "priceToBook": 7.52809314359638, "currentRatio": 1.30064397424103, "dividendYield": -0.000206213345577824, "returnOnAssets": 0.008143977478383269, "returnOnEquity": -0.293143596377749, "analystOpinions": null, "businessSummary": "The Estée Lauder Companies Inc. (/ˈɛsteɪ ˈlɔːdər/ EST-ay LAW-dər) is an American multinational cosmetics company, a manufacturer and marketer of makeup, skincare, perfume, and hair care products, based in Midtown Manhattan, New York City. It is the second largest cosmetics company in the world after L'Oréal. The company owns a diverse portfolio of brands, including La Mer, Jo Malone London, Clinique and Tom Ford Beauty, among many more, distributed internationally through both digital commerce and retail channels.", "enterpriseValue": 33492080000, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 57000, "sharesOutstanding": null, "enterpriseToEbitda": 49.03672035139092, "analystTargetMedian": null, "enterpriseToRevenue": 7.919621659966896, "operatingCashflowTTM": 785000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:20:32.903Z" }, "results": [ { "id": "cmnr13hjn03i6p658qkygiut1", "runId": "cmnr13hjl03i4p65811qbwwz4", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"AI Equity Research Model v1.0\",\"as_of\":\"2026-04-08T20:00:03.000Z\",\"ticker\":\"EL\",\"currency\":\"USD\",\"current_price\":71.44,\"target_price_6m\":65.0,\"target_price_12m\":62.0,\"recommendation\":\"SELL\",\"confidence\":0.57,\"thesis_bullets\":[\"Negative TTM EPS and deeply depressed operating margins signal structural headwinds\",\"EV/EBITDA of 49x prices in aggressive recovery not yet supported by fundamentals\",\"High net debt (~$4.4B) constrains financial flexibility during turnaround\",\"Revenue decline of ~70% YoY reflects severe demand weakness in key channels\",\"Brand portfolio remains premium but turnaround timeline is highly uncertain\"],\"key_drivers\":[{\"driver\":\"China/travel retail channel recovery trajectory\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Restructuring execution under new CEO\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Operating margin compression well below historical 15-18% norms\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Elevated leverage with debt/equity near 1.9x\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Prestige beauty category structural growth tailwind\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Competitive pressure from indie and digital-native brands\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"FX headwinds on international revenues\",\"impact\":\"LOW\",\"direction\":\"NEG\"},{\"driver\":\"Positive FCF ($407M TTM) provides some cushion\",\"impact\":\"MED\",\"direction\":\"POS\"}],\"risks\":[\"Recovery in China/Asia travel retail takes longer than expected\",\"Debt servicing costs rise if rates stay elevated, pressuring thin margins\",\"Restructuring charges mask underlying earnings trajectory for multiple quarters\",\"Consumer trade-down from prestige to mass beauty accelerates\",\"Key brand equity erosion under cost-cutting measures\",\"Forward PE of 37x still demands significant earnings inflection\"],\"assumptions\":{\"revenue_cagr_3y\":-0.05,\"ebit_margin_target\":0.12,\"wacc\":0.10,\"terminal_multiple\":16.0},\"scenarios\":{\"bear\":{\"target_price\":48.0,\"prob\":0.25,\"notes\":\"Recovery stalls, revenue declines persist, stock retests 52-week lows.\"},\"base\":{\"target_price\":62.0,\"prob\":0.50,\"notes\":\"Gradual stabilization but valuation compresses as recovery disappoints expectations.\"},\"bull\":{\"target_price\":85.0,\"prob\":0.25,\"notes\":\"Meaningful channel recovery and margin improvement restore earnings growth narrative.\"}},\"method_notes\":\"Blended EV/EBITDA and normalized earnings-power valuation. At 49x EV/EBITDA, current price embeds recovery not yet visible in fundamentals. TTM revenue of $4.2B and negative EPS warrant caution. Base case assumes slow margin normalization toward 12% EBIT margin on modest revenue stabilization, yielding ~$62 fair value. Probability-weighted scenario value ($62.75) aligns with 12M target. Sell-side targets not used as inputs. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "AI Equity Research Model v1.0", "risks": [ "Recovery in China/Asia travel retail takes longer than expected", "Debt servicing costs rise if rates stay elevated, pressuring thin margins", "Restructuring charges mask underlying earnings trajectory for multiple quarters", "Consumer trade-down from prestige to mass beauty accelerates", "Key brand equity erosion under cost-cutting measures", "Forward PE of 37x still demands significant earnings inflection" ], "ticker": "EL", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Gradual stabilization but valuation compresses as recovery disappoints expectations.", "target_price": 62 }, "bear": { "prob": 0.25, "notes": "Recovery stalls, revenue declines persist, stock retests 52-week lows.", "target_price": 48 }, "bull": { "prob": 0.25, "notes": "Meaningful channel recovery and margin improvement restore earnings growth narrative.", "target_price": 85 } }, "confidence": 0.57, "assumptions": { "wacc": 0.1, "revenue_cagr_3y": -0.05, "terminal_multiple": 16, "ebit_margin_target": 0.12 }, "key_drivers": [ { "driver": "China/travel retail channel recovery trajectory", "impact": "HIGH", "direction": "NEG" }, { "driver": "Restructuring execution under new CEO", "impact": "HIGH", "direction": "POS" }, { "driver": "Operating margin compression well below historical 15-18% norms", "impact": "HIGH", "direction": "NEG" }, { "driver": "Elevated leverage with debt/equity near 1.9x", "impact": "MED", "direction": "NEG" }, { "driver": "Prestige beauty category structural growth tailwind", "impact": "MED", "direction": "POS" }, { "driver": "Competitive pressure from indie and digital-native brands", "impact": "MED", "direction": "NEG" }, { "driver": "FX headwinds on international revenues", "impact": "LOW", "direction": "NEG" }, { "driver": "Positive FCF ($407M TTM) provides some cushion", "impact": "MED", "direction": "POS" } ], "method_notes": "Blended EV/EBITDA and normalized earnings-power valuation. At 49x EV/EBITDA, current price embeds recovery not yet visible in fundamentals. TTM revenue of $4.2B and negative EPS warrant caution. Base case assumes slow margin normalization toward 12% EBIT margin on modest revenue stabilization, yielding ~$62 fair value. Probability-weighted scenario value ($62.75) aligns with 12M target. Sell-side targets not used as inputs. Not investment advice.", "current_price": 71.44, "recommendation": "SELL", "thesis_bullets": [ "Negative TTM EPS and deeply depressed operating margins signal structural headwinds", "EV/EBITDA of 49x prices in aggressive recovery not yet supported by fundamentals", "High net debt (~$4.4B) constrains financial flexibility during turnaround", "Revenue decline of ~70% YoY reflects severe demand weakness in key channels", "Brand portfolio remains premium but turnaround timeline is highly uncertain" ], "target_price_6m": 65, "target_price_12m": 62 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 50248, "createdAt": "2026-04-09T05:20:32.911Z", "usage": { "inputTokens": 3665, "outputTokens": 2205, "costUsd": 0.07345 } }, { "id": "cmnr13hjn03i9p6583tqu0rl6", "runId": "cmnr13hjl03i4p65811qbwwz4", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI_Equity_Research_Model\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"EL\",\n \"currency\": \"USD\",\n \"current_price\": 71.44,\n \"target_price_6m\": 73.0,\n \"target_price_12m\": 75.0,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\"Strong brand portfolio with global presence.\", \"Recent revenue decline poses challenges.\", \"High gross margins support profitability potential.\", \"Debt levels are elevated, increasing financial risk.\", \"Valuation appears high relative to current earnings.\"],\n \"key_drivers\": [\n {\"driver\": \"Revenue growth recovery\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"EBIT margin improvement\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Debt reduction efforts\", \"impact\": \"LOW\", \"direction\": \"POS\"},\n {\"driver\": \"Consumer spending trends\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Competition intensity\", \"impact\": \"HIGH\", \"direction\": \"NEG\"},\n {\"driver\": \"Digital sales growth\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Economic conditions\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n {\"driver\": \"Product innovation\", \"impact\": \"LOW\", \"direction\": \"POS\"}\n ],\n \"risks\": [\"Prolonged revenue decline.\", \"Increased competition from rivals.\", \"Economic downturn affecting luxury sales.\", \"High debt burden limiting flexibility.\"],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.04,\n \"ebit_margin_target\": 0.11,\n \"wacc\": 0.085,\n \"terminal_multiple\": 13\n },\n \"scenarios\": {\n \"bear\": {\"target_price\": 60, \"prob\": 0.3, \"notes\": \"Continued decline in sales and margins.\"},\n \"base\": {\"target_price\": 75, \"prob\": 0.5, \"notes\": \"Moderate recovery with steady growth.\"},\n \"bull\": {\"target_price\": 90, \"prob\": 0.2, \"notes\": \"Strong turnaround and market share gains.\"}\n },\n \"method_notes\": \"DCF valuation with scenario analysis. Expected return ~5% leads to HOLD. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "AI_Equity_Research_Model", "risks": [ "Prolonged revenue decline.", "Increased competition from rivals.", "Economic downturn affecting luxury sales.", "High debt burden limiting flexibility." ], "ticker": "EL", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Moderate recovery with steady growth.", "target_price": 75 }, "bear": { "prob": 0.3, "notes": "Continued decline in sales and margins.", "target_price": 60 }, "bull": { "prob": 0.2, "notes": "Strong turnaround and market share gains.", "target_price": 90 } }, "confidence": 0.6, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.04, "terminal_multiple": 13, "ebit_margin_target": 0.11 }, "key_drivers": [ { "driver": "Revenue growth recovery", "impact": "MED", "direction": "POS" }, { "driver": "EBIT margin improvement", "impact": "MED", "direction": "POS" }, { "driver": "Debt reduction efforts", "impact": "LOW", "direction": "POS" }, { "driver": "Consumer spending trends", "impact": "MED", "direction": "POS" }, { "driver": "Competition intensity", "impact": "HIGH", "direction": "NEG" }, { "driver": "Digital sales growth", "impact": "MED", "direction": "POS" }, { "driver": "Economic conditions", "impact": "MED", "direction": "NEG" }, { "driver": "Product innovation", "impact": "LOW", "direction": "POS" } ], "method_notes": "DCF valuation with scenario analysis. Expected return ~5% leads to HOLD. Not investment advice.", "current_price": 71.44, "recommendation": "HOLD", "thesis_bullets": [ "Strong brand portfolio with global presence.", "Recent revenue decline poses challenges.", "High gross margins support profitability potential.", "Debt levels are elevated, increasing financial risk.", "Valuation appears high relative to current earnings." ], "target_price_6m": 73, "target_price_12m": 75 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 350, "createdAt": "2026-04-09T05:20:32.911Z", "usage": { "inputTokens": 2156, "outputTokens": 4215, "costUsd": 0.002374 } }, { "id": "cmnr13hjn03i7p658gaa1j51g", "runId": "cmnr13hjl03i4p65811qbwwz4", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Equity Analyst\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"EL\",\n \"currency\": \"USD\",\n \"current_price\": 71.44,\n \"target_price_6m\": 68.00,\n \"target_price_12m\": 64.00,\n \"recommendation\": \"SELL\",\n \"confidence\": 0.7,\n \"thesis_bullets\": [\n \"Valuation is stretched at 37x forward PE despite negative TTM earnings and declining revenues.\",\n \"Prolonged weakness in Asia travel retail continues to weigh heavily on top-line growth.\",\n \"High leverage with a Debt/Equity of 1.89 limits capital allocation flexibility during the turnaround.\",\n \"Margin recovery is largely priced in, leaving little room for execution missteps.\",\n \"Intense competition in prestige beauty threatens market share in key North American and Chinese markets.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Asia Travel Retail Weakness\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Inventory Destocking\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Cost Savings Program\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Prestige Beauty Competition\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Debt Servicing Costs\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"China Macroeconomic Stimulus\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Faster-than-expected recovery in Chinese consumer spending and travel retail.\",\n \"Successful execution of the profit recovery plan driving rapid margin expansion.\",\n \"Potential acquisition target given the depressed share price relative to historical highs.\",\n \"New product innovations gaining unexpected traction in the US market.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.02,\n \"ebit_margin_target\": 0.12,\n \"wacc\": 0.085,\n \"terminal_multiple\": 18.0\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 50.00,\n \"prob\": 0.35,\n \"notes\": \"Turnaround fails, China remains weak, and margins stagnate, leading to multiple contraction.\"\n },\n \"base\": {\n \"target_price\": 64.00,\n \"prob\": 0.5,\n \"notes\": \"Sluggish top-line recovery and partial margin improvement fail to justify the current 37x forward PE.\"\n },\n \"bull\": {\n \"target_price\": 85.00,\n \"prob\": 0.15,\n \"notes\": \"Rapid recovery in Asia travel retail and successful cost-cutting drive earnings above consensus.\"\n }\n },\n \"method_notes\": \"DCF and EV/EBITDA multiple valuation. Stretched 37x forward PE and 49x EV/EBITDA limit upside. Base case assumes slow margin recovery, yielding a $64 target. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "AI Equity Analyst", "risks": [ "Faster-than-expected recovery in Chinese consumer spending and travel retail.", "Successful execution of the profit recovery plan driving rapid margin expansion.", "Potential acquisition target given the depressed share price relative to historical highs.", "New product innovations gaining unexpected traction in the US market." ], "ticker": "EL", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Sluggish top-line recovery and partial margin improvement fail to justify the current 37x forward PE.", "target_price": 64 }, "bear": { "prob": 0.35, "notes": "Turnaround fails, China remains weak, and margins stagnate, leading to multiple contraction.", "target_price": 50 }, "bull": { "prob": 0.15, "notes": "Rapid recovery in Asia travel retail and successful cost-cutting drive earnings above consensus.", "target_price": 85 } }, "confidence": 0.7, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.02, "terminal_multiple": 18, "ebit_margin_target": 0.12 }, "key_drivers": [ { "driver": "Asia Travel Retail Weakness", "impact": "HIGH", "direction": "NEG" }, { "driver": "Inventory Destocking", "impact": "HIGH", "direction": "NEG" }, { "driver": "Cost Savings Program", "impact": "MED", "direction": "POS" }, { "driver": "Prestige Beauty Competition", "impact": "MED", "direction": "NEG" }, { "driver": "Debt Servicing Costs", "impact": "MED", "direction": "NEG" }, { "driver": "China Macroeconomic Stimulus", "impact": "MED", "direction": "POS" } ], "method_notes": "DCF and EV/EBITDA multiple valuation. Stretched 37x forward PE and 49x EV/EBITDA limit upside. Base case assumes slow margin recovery, yielding a $64 target. Not investment advice.", "current_price": 71.44, "recommendation": "SELL", "thesis_bullets": [ "Valuation is stretched at 37x forward PE despite negative TTM earnings and declining revenues.", "Prolonged weakness in Asia travel retail continues to weigh heavily on top-line growth.", "High leverage with a Debt/Equity of 1.89 limits capital allocation flexibility during the turnaround.", "Margin recovery is largely priced in, leaving little room for execution missteps.", "Intense competition in prestige beauty threatens market share in key North American and Chinese markets." ], "target_price_6m": 68, "target_price_12m": 64 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-pro-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 23144, "createdAt": "2026-04-09T05:20:32.911Z", "usage": { "inputTokens": 2502, "outputTokens": 839, "costUsd": 0.015072 } }, { "id": "cmnr13hjn03i5p658ddhw5khe", "runId": "cmnr13hjl03i4p65811qbwwz4", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI gpt-5\",\"as_of\":\"2026-04-08T20:00:03.000Z\",\"ticker\":\"EL\",\"currency\":\"USD\",\"current_price\":71.44,\"target_price_6m\":73.8,\"target_price_12m\":75.2,\"recommendation\":\"HOLD\",\"confidence\":0.56,\"thesis_bullets\":[\"Premium skincare brands support long-run pricing power.\",\"China and travel-retail exposure still pressure near-term demand.\",\"Gross margin remains strong, but operating margin is still depressed.\",\"Positive free cash flow helps, yet leverage limits flexibility.\",\"Shares appear near fair value on gradual recovery assumptions.\"],\"key_drivers\":[{\"driver\":\"China demand normalization\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Travel retail reset\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Margin recovery execution\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Prestige beauty competition\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Leverage and interest burden\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"FX and APAC mix\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Innovation and hero brands\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Inventory discipline\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"China recovery stalls longer than expected.\",\"Travel-retail destocking persists.\",\"Margin recovery misses due to promotions.\",\"Leverage constrains capital allocation.\",\"Prestige beauty demand weakens in core markets.\"],\"assumptions\":{\"revenue_cagr_3y\":0.06,\"ebit_margin_target\":0.14,\"wacc\":0.095,\"terminal_multiple\":18},\"scenarios\":{\"bear\":{\"target_price\":56,\"prob\":0.3,\"notes\":\"Demand stays soft and margin rebuild is delayed.\"},\"base\":{\"target_price\":75.2,\"prob\":0.5,\"notes\":\"Sales stabilize and margins recover gradually over 12 months.\"},\"bull\":{\"target_price\":96,\"prob\":0.2,\"notes\":\"China rebounds faster and restructuring lifts profits materially.\"}},\"method_notes\":\"Used snapshot quote/fundamentals only. Blended normalized EV/EBIT with cash-flow sanity check; snapshot growth appears trough-distorted, so targets assume gradual normalization and do not use sell-side targets. Base-case 12M upside is ~5%, so HOLD; not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "OpenAI gpt-5", "risks": [ "China recovery stalls longer than expected.", "Travel-retail destocking persists.", "Margin recovery misses due to promotions.", "Leverage constrains capital allocation.", "Prestige beauty demand weakens in core markets." ], "ticker": "EL", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Sales stabilize and margins recover gradually over 12 months.", "target_price": 75.2 }, "bear": { "prob": 0.3, "notes": "Demand stays soft and margin rebuild is delayed.", "target_price": 56 }, "bull": { "prob": 0.2, "notes": "China rebounds faster and restructuring lifts profits materially.", "target_price": 96 } }, "confidence": 0.56, "assumptions": { "wacc": 0.095, "revenue_cagr_3y": 0.06, "terminal_multiple": 18, "ebit_margin_target": 0.14 }, "key_drivers": [ { "driver": "China demand normalization", "impact": "HIGH", "direction": "POS" }, { "driver": "Travel retail reset", "impact": "HIGH", "direction": "POS" }, { "driver": "Margin recovery execution", "impact": "HIGH", "direction": "POS" }, { "driver": "Prestige beauty competition", "impact": "MED", "direction": "NEG" }, { "driver": "Leverage and interest burden", "impact": "MED", "direction": "NEG" }, { "driver": "FX and APAC mix", "impact": "MED", "direction": "NEG" }, { "driver": "Innovation and hero brands", "impact": "MED", "direction": "POS" }, { "driver": "Inventory discipline", "impact": "LOW", "direction": "POS" } ], "method_notes": "Used snapshot quote/fundamentals only. Blended normalized EV/EBIT with cash-flow sanity check; snapshot growth appears trough-distorted, so targets assume gradual normalization and do not use sell-side targets. Base-case 12M upside is ~5%, so HOLD; not investment advice.", "current_price": 71.44, "recommendation": "HOLD", "thesis_bullets": [ "Premium skincare brands support long-run pricing power.", "China and travel-retail exposure still pressure near-term demand.", "Gross margin remains strong, but operating margin is still depressed.", "Positive free cash flow helps, yet leverage limits flexibility.", "Shares appear near fair value on gradual recovery assumptions." ], "target_price_6m": 73.8, "target_price_12m": 75.2 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_0d962d0af2e134db0069d7589064b48197b996a58baaa6d98a", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 49612, "createdAt": "2026-04-09T05:20:32.911Z", "usage": { "inputTokens": 2425, "outputTokens": 2556, "costUsd": 0.040028 } }, { "id": "cmnr13hjn03i8p658frl6ukb0", "runId": "cmnr13hjl03i4p65811qbwwz4", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Hybrid DCF Valuation Model\",\n \"as_of\": \"2026-04-08T20:00:03.000Z\",\n \"ticker\": \"EL\",\n \"currency\": \"USD\",\n \"current_price\": 71.44,\n \"target_price_6m\": 78.5,\n \"target_price_12m\": 85,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.62,\n \"thesis_bullets\": [\n \"Iconic brands support long-term loyalty\",\n \"Revenue trends showing early stabilization\",\n \"Cost cuts to drive margin expansion\",\n \"China weakness pressures near-term sales\",\n \"Stock decline offers attractive entry\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"China demand recovery\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Cost optimization program\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Prestige beauty market growth\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"High leverage and interest costs\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Product innovation pipeline\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Intense competitive pressure\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Macro consumer spending\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Prolonged Asia market slowdown\",\n \"Margin expansion execution risk\",\n \"Rising competition from rivals\",\n \"Adverse foreign exchange moves\",\n \"Debt levels limiting flexibility\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.05,\n \"ebit_margin_target\": 0.13,\n \"wacc\": 0.085,\n \"terminal_multiple\": 18\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 58,\n \"prob\": 0.3,\n \"notes\": \"Extended China weakness and stalled margins.\"\n },\n \"base\": {\n \"target_price\": 85,\n \"prob\": 0.5,\n \"notes\": \"Gradual recovery with moderate margin gains.\"\n },\n \"bull\": {\n \"target_price\": 110,\n \"prob\": 0.2,\n \"notes\": \"Strong innovation and market share gains.\"\n }\n },\n \"method_notes\": \"3-stage DCF with 5% rev CAGR, 13% EBIT target, 8.5% WACC and 18x terminal EV/EBITDA. 19% implied upside supports BUY. not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:03.000Z", "model": "Hybrid DCF Valuation Model", "risks": [ "Prolonged Asia market slowdown", "Margin expansion execution risk", "Rising competition from rivals", "Adverse foreign exchange moves", "Debt levels limiting flexibility" ], "ticker": "EL", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Gradual recovery with moderate margin gains.", "target_price": 85 }, "bear": { "prob": 0.3, "notes": "Extended China weakness and stalled margins.", "target_price": 58 }, "bull": { "prob": 0.2, "notes": "Strong innovation and market share gains.", "target_price": 110 } }, "confidence": 0.62, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.05, "terminal_multiple": 18, "ebit_margin_target": 0.13 }, "key_drivers": [ { "driver": "China demand recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Cost optimization program", "impact": "HIGH", "direction": "POS" }, { "driver": "Prestige beauty market growth", "impact": "MED", "direction": "POS" }, { "driver": "High leverage and interest costs", "impact": "MED", "direction": "NEG" }, { "driver": "Product innovation pipeline", "impact": "MED", "direction": "POS" }, { "driver": "Intense competitive pressure", "impact": "MED", "direction": "NEG" }, { "driver": "Macro consumer spending", "impact": "HIGH", "direction": "NEG" } ], "method_notes": "3-stage DCF with 5% rev CAGR, 13% EBIT target, 8.5% WACC and 18x terminal EV/EBITDA. 19% implied upside supports BUY. not investment advice.", "current_price": 71.44, "recommendation": "BUY", "thesis_bullets": [ "Iconic brands support long-term loyalty", "Revenue trends showing early stabilization", "Cost cuts to drive margin expansion", "China weakness pressures near-term sales", "Stock decline offers attractive entry" ], "target_price_6m": 78.5, "target_price_12m": 85 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "782bc1ae-87e5-94d7-be66-6b21481a9ceb", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 15059, "createdAt": "2026-04-09T05:20:32.911Z", "usage": { "inputTokens": 2767, "outputTokens": 3193, "costUsd": 0.056196 } } ] } }